Long-term outcomes of elderly patients with peritoneal metastases of colorectal origin after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

[1]  D. Schrag,et al.  Patterns of Adjuvant Chemotherapy Use and Association With Survival in Adults 80 Years and Older With Pancreatic Adenocarcinoma. , 2021, JAMA oncology.

[2]  B. Haas,et al.  All-Cause and Cancer-Specific Death of Older Adults Following Surgery for Cancer. , 2021, JAMA surgery.

[3]  D. Brennan,et al.  Short-term outcomes in older patients with peritoneal malignancy treated with cytoreductive surgery and HIPEC: Experience with 245 patients from a national centre. , 2021, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[4]  M. Pocard,et al.  Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. , 2021, The Lancet. Oncology.

[5]  X. Lenne,et al.  Centralization and Oncologic Training Reduce Postoperative Morbidity and Failure-to-rescue Rates After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies: Study on a 10-year National French Practice. , 2020, Annals of surgery.

[6]  C. Punt,et al.  Adjuvant Systemic Chemotherapy vs Active Surveillance Following Up-front Resection of Isolated Synchronous Colorectal Peritoneal Metastases. , 2020, JAMA oncology.

[7]  D. Papamichael,et al.  Adjuvant chemotherapy in patients with colorectal cancer. Is there a role in the older adult? , 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[8]  N. Hyman,et al.  Peritoneal Metastases in Colorectal Cancer: Biology and Barriers , 2019, Journal of Gastrointestinal Surgery.

[9]  J. Burger,et al.  Short-term complications in elderly patients undergoing CRS and HIPEC: A single center's initial experience. , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[10]  L. Battaglia,et al.  Learning Curve, Training Program, and Monitorization of Surgical Performance of Peritoneal Surface Malignancies Centers. , 2018, Surgical oncology clinics of North America.

[11]  K. Soo,et al.  Morbidity and mortality of elderly patients following cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) , 2018 .

[12]  R. Kanesvaran,et al.  Quality of life of elderly patients with solid tumours undergoing adjuvant cancer therapy: a systematic review , 2018, BMJ Open.

[13]  P. Parrilla,et al.  Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei and appendix tumours in elderly patients: Is it justified? , 2017, Clinical and Translational Oncology.

[14]  C. Punt,et al.  Perioperative systemic therapy for resectable colorectal peritoneal metastases: Sufficient evidence for its widespread use? A critical systematic review. , 2017, Critical reviews in oncology/hematology.

[15]  E. Feliciangeli,et al.  Morbidity and mortality outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients aged 75 years and over: Spanish group of peritoneal cancer surgery (GECOP) multicenter study. , 2016, Surgical oncology.

[16]  F. Pietrantonio,et al.  Progress in treatments for colorectal cancer peritoneal metastases during the years 2010-2015. A systematic review. , 2016, Critical reviews in oncology/hematology.

[17]  H. Alexander,et al.  Then and now: cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC), a historical perspective. , 2016, Journal of gastrointestinal oncology.

[18]  C. Lepage,et al.  Epidemiology, Management, and Survival of Peritoneal Carcinomatosis from Colorectal Cancer: A Population-Based Study , 2015, Diseases of the colon and rectum.

[19]  P. Parrilla,et al.  Cytoreduction and HIPEC after neoadjuvant chemotherapy in stage IIIC-IV ovarian cancer. Critical analysis in elderly patients. , 2014, European journal of obstetrics, gynecology, and reproductive biology.

[20]  P. Pattyn,et al.  Neoadjuvant Chemotherapy with Bevacizumab May Improve Outcome after Cytoreduction and Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) for Colorectal Carcinomatosis , 2014, Annals of Surgical Oncology.

[21]  J. Spiliotis,et al.  Cytoreductive Surgery and HIPEC for Peritoneal Carcinomatosis in the Elderly , 2014, International Journal of Surgical Oncology.

[22]  S. Hiotis,et al.  Outcomes for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the elderly. , 2013, Surgical oncology.

[23]  E. Cotte,et al.  Progression Following Neoadjuvant Systemic Chemotherapy May Not Be a Contraindication to a Curative Approach for Colorectal Carcinomatosis , 2012, Annals of surgery.

[24]  P. Nygren,et al.  Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: prognosis and treatment of recurrences in a cohort study. , 2012, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[25]  F. Granath,et al.  Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer , 2012, The British journal of surgery.

[26]  T. Chua,et al.  Outcomes of elderly patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal cancer peritoneal carcinomatosis , 2012, Journal of surgical oncology.

[27]  G. Trimarchi,et al.  Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in elderly patients. , 2011, In vivo.

[28]  M. Deraco,et al.  Surgical technique of parietal and visceral peritonectomy for peritoneal surface malignancies , 2009, Journal of surgical oncology.

[29]  J. Šimša,et al.  Cytoreductive surgery in the elderly patients--is it feasible? , 2008, Hepato-Gastroenterology.

[30]  F. Gilly.  Phase II studies: International registry of colorectal carcinomatosis. , 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[31]  F. Kwiatkowski,et al.  Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.

[33]  H. van Tinteren,et al.  Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  D. Jayne,et al.  Peritoneal carcinomatosis from colorectal cancer , 2002, The British journal of surgery.

[35]  J. Faure,et al.  Peritoneal carcinomatosis from non‐gynecologic malignancies , 2000, Cancer.

[36]  F. F. Paul H. Sugarbaker MD,et al.  Management for Peritoneal Metastasis of Colonic Origin: Role of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy: A Single Institution’s Experience During Two Decades , 2016, Annals of Surgical Oncology.

[37]  Mbbs Mrcs Kathryn Waite BSc,et al.  The Role of Neoadjuvant and Adjuvant Systemic Chemotherapy with Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Systematic Review , 2016, Annals of Surgical Oncology.

[38]  N. Petrelli,et al.  Consensus Guidelines from The American Society of Peritoneal Surface Malignancies on Standardizing the Delivery of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer Patients in the United States , 2013, Annals of Surgical Oncology.

[39]  D. Elias,et al.  Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.